Key result
Mitral surgery after failed M-TEER is linked to ~12% early mortality, predominantly involving valve replacement.
Why the study?
Pooled early all-cause mortality and feasibility of surgical repair after failed MitraClip or transcatheter edge-to-edge repair had not been reliably estimated across the retrospective evidence base.
Population
951 adults across 8 unique surgical cohorts undergoing mitral surgery after failed MitraClip/TEER
Design
Systematic review and single-arm meta-analysis
Follow-up
Operative, in-hospital, or 30 days
Authors
Loading...
Substantial early mortality after surgery for failed TEER warrants caution in referral decisions; leaves open optimal strategy versus alternatives pending prospective data.
Meta-Analysis (n=951)
Effect estimate: 11.7% (95% CI 8.4-16.0)
Mitral surgery after failed transcatheter edge-to-edge repair is associated with substantial early mortality (11.7%) and low repair feasibility (12.5%), with valve replacement remaining the predominant strategy.
Campailla et al. (2026) conducted a meta-analysis in Failed MitraClip/TEER requiring mitral surgery (n=951). Mitral surgery after failed M-TEER was evaluated on Early all-cause mortality (mixed-definition: operative, in-hospital, or 30-day) (11.7%, 95% CI 8.4-16.0). Mitral surgery after failed transcatheter edge-to-edge repair is associated with a pooled early all-cause mortality of 11.7%, with valve replacement remaining the predominant surgical strategy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: